Editorial Comment [0.03%]
编者按
Chad R Ritch
Chad R Ritch
Patient Participation in Consultations for Clinically Localized Prostate Cancer [0.03%]
局限性前列腺癌患者就诊时的参与情况
Paul Kokorowski,Nadine A Friedrich,Michael Luu et al.
Paul Kokorowski et al.
Purpose: Shared decision making (SDM) for prostate cancer treatment requires active participation of patients and providers. While the physician's role has been studied extensively, the patient's role in SDM is poorly cha...
A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children with Known Vesicoureteral Reflux [0.03%]
预测已知输尿管膀胱反流儿童停用连续抗生素预防后的发热性泌尿系感染的危险分层模型
Suhaib Abdulfattah,Nicole J Kye,Avi P Shah et al.
Suhaib Abdulfattah et al.
Purpose: This study evaluates the clinical characteristics and predictors of febrile urinary tract infection in children with potentially persistent primary vesicoureteral reflux (VUR) who discontinued continuous antibiot...
Sexual Health [0.03%]
性健康
Mohit Khera
Mohit Khera
Sean P Elliott
Sean P Elliott
A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation: Erratum [0.03%]
多机构合作利用磁共振/超声融合引导的纳米颗粒定向消融治疗前列腺癌的研究：更正意见通知书
Steven E Canfield,Arvin K George,Joshua S Jue et al.
Steven E Canfield et al.
Published Erratum
The Journal of urology. 2025 Nov;214(5):557. DOI:10.1097/JU.0000000000004688 2025
Identifying Risk of Progression Among Patients With Biochemical Recurrence Remains a Challenge [0.03%]
确定生化复发患者的进展风险仍是一项挑战
Bryn M Launer,Ashley Pittman,Kelvin A Moses
Bryn M Launer
PD11-09 A Phase 2 Randomized, Placebo-Controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-Rich Plasma Injections for Peyronie's Disease: Clinical Trial Update: Erratum [0.03%]
PLEXUS11-09：阴茎血小板丰富血浆注射治疗佩罗尼病的安全性与有效性的2期随机、对照交叉试验临床试验更新：勘误表
Manuel Molina,Laura Angulo-Llanos,Kristin Perrucci et al.
Manuel Molina et al.